Added benefit of the fixed combination of dapagliflozin and metformin is not proven
The fixed combination of the drugs dapagliflozin and metformin (trade name: Xigduo) has been approved since January 2014 for adults with type 2 diabetes in whom diet and exercise do not provide adequate glycaemic control. ...
May 15, 2014